In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
New reporting process “Reporting Centre for drug shortages and defects”

New reporting process “Reporting Centre for drug shortages and defects”

by In2Pharma | Feb 16, 2022 | News

The Netherlands Medicinal Product Quality Defects and Shortages on the Dutch Market should be reported through the “Meldpunt geneesmiddelentekorten en -defecten”. As of 01 January 2022, the Medicines Evaluation Board (MEB) and the Inspectorate (IGJ) have implemented...

Recent Posts

  • Verify Luxembourg MA Numbers in XEVMPD
  • Rates advice KOAGKAG
  • Announcement of changes in EU pharmacovigilance legislation
  • New European regulation for Health Technology Assessment
  • Pharma.be supports interactions with patients

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België